Home World Politics Business Tech Health Science Climate Education

Balanced coverage of the week's biggest story. See every side. Know the truth.

By signing up for the Story of the Week newsletter you agree to our privacy policy.

Product

For You
Trending
Blindspot
Local
Compare
Brief
Trust

Topics

World
Politics
Business
Tech
Health
Science

Regions

Africa
Europe
Asia-Pacific
Americas
Middle East

Company

About
Contact
All topics
My Bias
Privacy
Terms & DMCA
Partner Offers

KODAWIRE

KODAWIRE

© 2026 Kodawire

About Contact Privacy Terms Top

/

/

uniQure plunges after new trial data for Huntington’s disease therapy

1 sources

Seeking Alpha (US)4h ago

Center

uniQure plunges after new trial data for Huntington’s disease therapy

uniQure (QURE) stock plunges as new trial data for gene therapy candidate AMT-130 in Huntington’s disease disappoint investors. Read more here.

Spectrum

L 0%C 100%R 0%